NCR102

· Nuwacell Biotechnologies Co., Ltd.

Drug timelines are a Plus or Pro feature.

1 regulatory and trial event tracked for NCR102, covering 2025-04-23 to 2025-04-23. Get the full timeline:

Most recent: Clinical Trial Update: A Trial to Evaluate the Safety and Efficacy of NCR102 in Subjects With aGVHD [Phase 1, Phase 2]